All lobbying filings

TODD STRATEGY GROUP

TODD STRATEGY GROUP filed a Q3 report for INOVIO PHARMACEUTICALS on October 27, 2026, reporting $60,000 in lobbying income.

Lobbying for INOVIO PHARMACEUTICALS · Biotechnology company.

All filings by TODD STRATEGY GROUP · Everything INOVIO PHARMACEUTICALS has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 27, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Lobbyists on this filing 3

ERIC BERGREN

Previously held: Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker
PAUL EDATTEL

Previously held: Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
NICHOLAS UEHLECKE

Previously held: Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 1

Health Issues

General issues related to rare disease and orphan drugs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.